PDB Entry - 4NCG

(Status - Released)

Summary information:

Title: Discovery of Doravirine, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses

PDB DOI: https://doi.org/10.2210/pdb4ncg/pdb

Primary publication DOI: https://doi.org/10.1016/j.bmcl.2013.12.070

Entry authors: Yan, Y.

Initial deposition on: 24 October 2013

Initial release on: 12 February 2014

Latest revision on: 12 October 2022

Downloads:

Structure coordinates (PDBx/mmCIF)

Structure coordinates (PDBML)

Structure coordinates (PDB)

X-ray diffraction data (PDBx/mmCIF)

Validation report (mmCIF)

Validation report (PDF)

Validation report (XML)

Links to more resources for 4NCG at: